The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia

Azmi, Soraya; Goh, Adrian; Muhammad, Noor Azimah; Tohid, Hizlinda; Rashid, Mohd Radzniwan A

doi:10.1016/j.vhri.2017.06.002

Cited by 16 publications

(24 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ten studies were observational cross-sectional studies, one study was a modeling study and another one was a randomized-controlled trial. Two-thirds ( n = 8) of the studies were conducted by local researchers in healthcare facilities in Malaysia [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 ]. Six international studies were initially identified during the selection process.…”

Section: Resultsmentioning

confidence: 99%

“…Another two studies that reported data at the aggregate level [ 38 , 39 ] were excluded in our analysis as they did not provide detailed country-specific cost estimates of diabetes. The remaining studies were region specific that included one study from the Peninsular Malaysia [ 33 ], one study in the state of Penang [ 30 ], two studies in the state of Kelantan [ 26 , 29 ], one study in the state of Selangor [ 28 ] and two studies in the Federal Territories of Kuala Lumpur [ 27 , 32 ]. The majority of the studies had sample size that ranged between 100 to 3500 (six studies) [ 26 , 28 , 29 , 32 , 33 , 36 ], three studies had sample sizes of less than 100 [ 27 , 30 , 34 ] and another three studies had no sample sizes calculated, as they used secondary data [ 31 , 35 , 37 ].…”

Section: Resultsmentioning

confidence: 99%

“…The prevalence-based approach is applied to estimate the economic burden that is attributed to the prevalence of cases over a specific period of time, while the incidence-based approach involves analyzing the cost of diabetes over a given period of time [ 41 ]. In this review, most studies ( n = 10) estimated the cost of diabetes using the prevalence-based approach [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 36 , 37 ], while two studies used an incidence-based approach for cost estimation [ 34 , 35 ].…”

Section: Resultsmentioning

confidence: 99%

“…A global study estimated the cost of diabetes by using country-by-country expenditures [ 37 ]. Six studies measured direct medical costs [ 30 , 31 , 33 , 34 , 35 , 36 ]. One study measured indirect and intangible costs [ 29 ].…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia

Ganasegeran

Hor

Jamil

et al. 2020

IJERPH

View full text Add to dashboard Cite

Diabetes causes significant disabilities, reduced quality of life and mortality that imposes huge economic burden on societies and governments worldwide. Malaysia suffers a high diabetes burden in Asia, but the magnitude of healthcare expenditures documented to aid national health policy decision-making is limited. This systematic review aimed to document the economic burden of diabetes in Malaysia, and identify the factors associated with cost burden and the methods used to evaluate costs. Studies conducted between 2000 and 2019 were retrieved using three international databases (PubMed, Scopus, EMBASE) and one local database (MyCite), as well as manual searches. Peer reviewed research articles in English and Malay on economic evaluations of adult type 2 diabetes conducted in Malaysia were included. The review was registered with PROSPERO (CRD42020151857), reported according to PRISMA and used a quality checklist adapted for cost of illness studies. Data were extracted using a data extraction sheet that included study characteristics, total costs, different costing methods and a scoring system to assess the quality of studies reviewed. The review identified twelve eligible studies that conducted cost evaluations of type 2 diabetes in Malaysia. Variation exists in the costs and methods used in these studies. For direct costs, four studies evaluated costs related to complications and drugs, and two studies were related to outpatient and inpatient costs each. Indirect and intangible costs were estimated in one study. Four studies estimated capital and recurrent costs. The estimated total annual cost of diabetes in Malaysia was approximately USD 600 million. Age, type of hospitals or health provider, length of inpatient stay and frequency of outpatient visits were significantly associated with costs. The most frequent epidemiological approach employed was prevalence-based (n = 10), while cost analysis was the most common costing approach used. The current review offers the first documented evidence on cost estimates of diabetes in Malaysia.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia

Ganasegeran

Hor

Jamil

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…A number pf studies has revealded that health care for people suffering diabetes mellitus is somewhat considerable [6,7,8,9,10]. This indicates that the diabetes mellitus is one of the tramendous deseases to overcome.…”

Section: Introductionmentioning

confidence: 99%

The Analysis of Outpatient Average Cost for Diabetes Mellitus Type II at Sanjiwani Hospital, Gianyar

Pratiwi¹,

Sari²

2019

Proceedings of the International Conference of Social Science

View full text Add to dashboard Cite

The study design took upon cross sectional and mix method approach. The quantitative data are collected through questionnaire method, while the qualitative data are collected through in-depth interview method. The samples are 96 subjects that infected with the DM type II. The finding shows medical cost that paid by the patients classified into the prescription cost and laboratory cost. Indirect cost component paid by the patients is the transportation cost in reaching the health facility. Prescription and laboratory cost are the highest direct medical cost that took toll on the patient. The average cost paid by the Diabetes Mellitus type II patients are Rp. 548.200,-, transportation cost of Rp. 60.300,-and income loss of Rp.363.200,-for every month per person. There is a significant relationship of education, household income, and social economy status with the direct cost, while the indirect cost only has a significant relationship with household income, and social economy status.

show abstract